MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-10379

  1. 8,320 Posts.
    lightbulb Created with Sketch. 805
    and the market is always rational, particularly when the narrative has been moulded to be MSB and SI are cash guzzling crooks with no approval on the near horizon and the average market observer sees Mesoblast as the company that had a crack at covid but failed absolutely and have nothing else to offer. We continue to wait for actual news....
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.